Polyclonal Antibody to Fibroblast Growth Factor Receptor 3 (FGFR3)Homo sapiens (Human)Polyclonal antibody

CD333; ACH; CEK2; JTK4; Achondroplasia; Thanatophoric Dwarfism

  • Polyclonal Antibody to Fibroblast Growth Factor Receptor 3 (FGFR3)Package and Components
  • Polyclonal Antibody to Fibroblast Growth Factor Receptor 3 (FGFR3)Package and Components
  • Polyclonal Antibody to Fibroblast Growth Factor Receptor 3 (FGFR3)Figure. DAB staining on IHC-P; Samples: Human Skin Cancer Tissue.
  • Polyclonal Antibody to Fibroblast Growth Factor Receptor 3 (FGFR3)Figure. DAB staining on IHC-P; Samples: Human Breast Cancer Tissue.
  • Polyclonal Antibody to Fibroblast Growth Factor Receptor 3 (FGFR3)Figure. DAB staining on IHC-P; Samples: Human Kidney Tissue.
  • PAB797Hu01.jpgFigure. Western Blot; Sample: Recombinant FGFR3, Human.
  • Polyclonal Antibody to Fibroblast Growth Factor Receptor 3 (FGFR3)Figure. Western Blot; Sample: Mouse Placenta Tissue.
  • CertificateISO9001: 2008, ISO13485: 2003 Registered

SPECIFITY

The antibody is a rabbit polyclonal antibody raised against FGFR3. It has been selected for its ability to recognize FGFR3 in immunohistochemical staining and western blotting.

USAGE

Western blotting: 1-5ug/ml
Immunocytochemistry in formalin fixed cells: 5-20ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
Immunohistochemistry in paraffin section: 5-20ug/ml
Enzyme-linked Immunosorbent Assay: 0.05-2ug/ml
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Reference

  • BMC MedicinePhenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cellsPubMed: PMC3694028